Magali Genevray

Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial

Andrew Davies, Francesco Merli, Biljana Mihaljević et al. · The Lancet Haematology · 2017 · 112 citations

Lymphoid Neoplasia, Medicine, Follicular Lymphoma +5

Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial

Marina Konopleva, Christoph Röllig, Jamie Cavenagh et al. · Blood Advances · 2022 · 68 citations · Full text

Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film‐coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease

Gustavo Varela‐Fascinetto, Corinne Benchimol, Rafael Reyes‐Acevedo et al. · Pediatric Transplantation · 2016 · 21 citations

Bioequivalence Study of Fluoxetine Hydrochloride in Healthy Volunteers

Thomas G. Keller, N. Cambon, Magali Genevray et al. · Arzneimittelforschung · 2011 · 12 citations